Home Journals Articles Updates About
CN
image
收藏切换
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
收藏切换
PDF
Jiaqing Yanga, Junhao Xua, Ziheng Qiua, Zhiyong Maoa, Xiaojun Xub, *, Ying Jianga, *, Guizhu Wuc, *
Acta Pharmaceutica Sinica B | 2025, 15(3) : 1696 - 1699
Less
收藏切换
Acta Pharmaceutica Sinica B | 2025, 15(3): 1696-1699
• LETTER TO THE EDITOR •
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
Full
Jiaqing Yanga, Junhao Xua, Ziheng Qiua, Zhiyong Maoa, Xiaojun Xub, *, Ying Jianga, *, Guizhu Wuc, *
Affiliations
  • aShanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China
  • bDepartment of Pharmacy, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Center for Innovative Traditional Chinese Medicine Target and New Drug Research, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China
  • cDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China
About Author:

E-mail addresses: (Xiaojun Xu)

(Ying Jiang)

(Guizhu Wu)

†

These authors made equal contributions to this work.

Author contributions

Jiaqing Yang: Writing – original draft, Data curation. Junhao Xu: Investigation, Data curation. Ziheng Qiu: Investigation. Zhiyong Mao: Writing – review & editing, Conceptualization. Xiaojun Xu: Writing – review & editing, Conceptualization. Ying Jiang: Supervision, Project administration, Investigation, Funding acquisition, Conceptualization. Guizhu Wu: Supervision, Project administration, Investigation, Funding acquisition, Conceptualization.

doi: 10.1016/j.apsb.2025.01.026
Outline
收藏切换
Cellular senescence  /  Lycorine hydrochloride  /  Ubiquitin-activating enzyme  /  UBA1
Jiaqing Yang, Junhao Xu, Ziheng Qiu, Zhiyong Mao, Xiaojun Xu, Ying Jiang, Guizhu Wu. Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence[J]. Acta Pharmaceutica Sinica B, 2025 , 15 (3) : 1696 -1699 . DOI: 10.1016/j.apsb.2025.01.026
Full Text
Less
To the Editor:
Aging is characterized by progressive functional decline, with the gradual loss of proteostasis being a widely acknowledged hallmark of the aging process. Direct evidence indicates a reduction in ubiquitination levels in aged worms1. Therefore, the development of therapeutics that target the ubiquitination pathways could offer substantial potential for delaying the onset of aging or age-related diseases.
UBA1 and UBA6 are two major ubiquitin-activating enzymes (E1s) identified in the human genome. UBA1 is particularly crucial, being responsible for the ubiquitination of over 99% of cellular proteins. Inhibition of UBA1 triggers apoptosis, which is particularly detrimental to cancer cells2. Furthermore, the loss of UBA1 function is closely linked to aging. In Drosophila, mutations in the Uba1 gene lead to a shortened adult lifespan, underscoring a connection between ubiquitination and longevity3. Decreased ubiquitination during aging has been documented, and enhancing the ubiquitination process by targeting UBA1 could present a clinical strategy to delay the onset of aging. However, the correlation between restored ubiquitination levels and aging effects warrants further investigation.
Our earlier research was the first to reveal that treatment with lycorine hydrochloride (LH) significantly delays the onset of stress-induced premature cellular senescence (SIPS)4. In this work, we proved that UBA1 is a direct target of lycorine hydrochloride, functioning as an activator of the enzyme. Furthermore, lycorine hydrochloride enhances UBA1 catalytic activity by strengthening the interaction between UBA1 and the E2 enzymes. This enhancement culminates in the amelioration of ubiquitination defects associated with cellular senescence in a UBA1-dependent manner. Consequently, this intervention suppresses the expression of specific senescence-associated secretory phenotype (SASP) factors and delays the onset of cellular senescence.
1.　Lycorine hydrochloride interacts with UBA1 at key residues Asp 504 and Lys 528
Less
To address the direct molecular targets of lycorine hydrochloride on mitigating cellular senescence, we identified a cohort of 16 proteins by employing a LiP-SMap assay (Supporting Information Table S1). Among them, the ubiquitin-like modifier-activating enzyme 1 (UBA1) is implicated in the aging process. Using surface plasmon resonance (SPR) assay, we confirmed that lycorine hydrochloride binds to UBA1 with high affinity, as evidenced by a dissociation constant (Kd) of 362.7 nmol/L (Supporting Information Fig. S1A). Moreover, we conducted a cellular thermal shift assay (CETSA) to substantiate the binding between lycorine hydrochloride and UBA1 (Fig. 1A, Fig. S1B). Collectively, these findings underscore a direct interaction between UBA1 and lycorine hydrochloride.
To identify the binding sites of lycorine hydrochloride on UBA1, we first employed molecular docking to make the prediction. The results revealed that the interaction is mediated by two critical amino acid residues in UBA1, Asp 504 and Lys 528, which are postulated to be ATP binding sites on UBA15 (Fig. S1C). Then, we created specific point mutations, converting Asp 504 and Lys 528 to alanine (Ala) to produce UBA1-D504A and UBA1-K528A mutants. We then conducted CESTA in cells expressing these mutants in the presence of DMSO or lycorine hydrochloride. In contrast to UBA1 WT, the mutants did not show the increased thermal stability conferred by lycorine hydrochloride (Fig. 1B, Fig. S1D), confirming the direct binding of lycorine hydrochloride to UBA1 through Asp 504 and Lys 528.
2.　Lycorine hydrochloride reverses ubiquitination decline in senescent cells through activating the enzymatic activity of UBA1
Less
Studies in Caenorhabditis elegans demonstrating a decline in ubiquitination levels during aging. Extending this investigation to mammals, we observed a similar decrease in ubiquitination in senescent human fibroblast cell lines and aged mouse tissues in compared to their younger counterparts (Fig. 1C, Supporting Information Fig. S2A). Considering the established role of lycorine hydrochloride in inhibiting SIPS and SASP, we propose that it may modulate ubiquitination to delay the onset of SIPS by interacting with UBA1.
Next, we evaluated the impact of lycorine hydrochloride on the ubiquitination level in senescent cells. We observed that lycorine hydrochloride increased ubiquitination in a dose-dependent manner (Fig. 1D). Additionally, the treatment did not alter the protein level of UBA1 (Fig. S2B), indicating that lycorine hydrochloride binding enhances UBA1 functionality and stimulates the ubiquitination process. Furthermore, we established a stable UBA1 knockdown cell line (Fig. S2C), the knockdown of UBA1 abolished the ubiquitination increase induced by lycorine hydrochloride (Fig. 1E), thereby confirming UBA1's essential role in mediating the restoration of ubiquitination levels in senescent cells by lycorine hydrochloride.
The conjugation of ubiquitin to E1 and its subsequent transfer to E2 are ATP-dependent steps critical to the ubiquitination process. We aimed to determine how lycorine hydrochloride, by binding to the ATP binding sites on UBA1, could enhance this process. An in vitro ubiquitination assay revealed an increase in ubiquitin conjugation to UBA1 in the presence of lycorine hydrochloride, while UBA1 mutants abolished the enhancement (Fig. S2D). We then identified E2 enzymes, specifically UBE2A, UBE2B, reported to act downstream of UBA16, UBE2D27, UBE2E38, reported to be associated with cellular senescence. Co-immunoprecipitation assays showed that lycorine hydrochloride specifically strengthened the interaction between UBA1 and UBE2A, UBE2D2 and UBE2E3, with no effect on the UBA1–UBE2B interaction. Notably, the UBA1-D504A and UBA1-K528A mutants eliminated the enhancing effect of lycorine hydrochloride on this interaction (Fig. 1F, Fig. S2E and F), indicating that lycorine hydrochloride facilitates the transfer of ubiquitin from UBA1 to E2s by enhancing the protein-protein interaction, thereby rescuing the decline in ubiquitination associated with cellular senescence.
3.　UBA1 knockdown abrogates the suppressive effects of lycorine hydrochloride on cellular senescence
Less
As lycorine hydrochloride presented potent effect on the onset of SIPS and the expression of SASP factors, we then conducted RT-qPCR and senescence-associated beta-galactosidase (SA-β gal) assay to elucidate the function of UBA1 in modulating the effects of lycorine hydrochloride on cellular senescence. RT-qPCR analysis revealed that lycorine hydrochloride markedly reduced the expression of SASP factors IL1α and IL1β in senescent cells, an effect that was partially reversed by UBA1 depletion (Fig. 2A). β-Gal staining further confirmed UBA1's role, showing an increase in positive cells upon UBA1 knockdown after lycorine hydrochloride treatment (Fig. 2B, Supporting Information Fig. S3A), indicative of a UBA1-dependent inhibition of SIPS by lycorine hydrochloride.
In conclusion, our study identifies UBA1 as a direct target of lycorine hydrochloride. By rescuing the decline in ubiquitin levels associated with aging, lycorine hydrochloride enhances UBA1's catalytic activity, impacting cellular senescence. A previous study identified auranofin, a small molecule compound, that binds to UBA1 and augments its enzymatic activity by promoting interactions with E2 enzymes6. This aligns with our own findings, suggesting a shared mechanism by which small molecules can regulate UBA1 activity. Given UBA1'grffs critical role at the onset of the ubiquitination cascade, the enhancing effects of these small molecules on UBA1 could potentially amplify its function. Consequently, this underscores UBA1 as a promising therapeutic target. Most notably, this research highlights the intricate relationship between ubiquitination and senescence, clarifies UBA1 as the molecular target of lycorine hydrochloride, and proposes a potential therapeutic strategy for treating senescence-related diseases.
References
Less
1.
Koyuncu S, Loureiro R, Lee HJ, Wagle P, Krueger M, Vilchez D. Rewiring of the ubiquitinated proteome determines ageing in C. elegans. Nature 2021;596:285—90.
2.
Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, et al. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med 2018;24:186—93.
3.
Liu HY, Pfleger CM. Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment. PLoS One 2013;8:e32835.
4.
Zhang W, Yang J, Chen Y, Xue R, Mao Z, Lu W, et al. Lycorine hydrochloride suppresses stress-induced premature cellular senescence by stabilizing the genome of human cells. Aging Cell 2021;20:e13307.
5.
Lv Z, Williams KM, Yuan L, Atkison JH, Olsen SK. Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity. J Biol Chem 2018;293:18337—52.
6.
Yan W, Zhong Y, Hu X, Xu T, Zhang Y, Kales S, et al. Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. Nat Commun 2023;14:4798.
7.
Hunt LC, Nyamkondiwa K, Stephan A, Jiao J, Kavdia K, Pagala V, et al. The ubiquitin-conjugating enzyme UBE2D/eff maintains a youthful proteome and ensures protein quality control during aging. bioRxiv 2024. https://doi.org/10.1101/2023.12.12.571303.
8.
Plafker KS, Zyla K, Berry W, Plafker SM. Loss of the ubiquitin conjugating enzyme UBE2E3 induces cellular senescence. Redox Biol 2018;17:411—22.
Appendix
Less
Year 2025 volume 15 Issue 3
PDF
11
8
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.01.026
  • Receive Date：2024-07-25
  • Online Date：2026-09-17
Article Data
Affiliations
History
  • Received：2024-07-25
  • Revised：2024-12-16
  • Accepted：2025-01-30
Affiliations
    aShanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China
    bDepartment of Pharmacy, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Center for Innovative Traditional Chinese Medicine Target and New Drug Research, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China
    cDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China

Corresponding:

* Corresponding authors.
References
Share
https://castjournals.cast.org.cn/joweb/apsb/EN/10.1016/j.apsb.2025.01.026
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House